Vertex Pharmaceuticals (NASDAQ: VRTX) was on track to become one of this year's biotech winners, with the shares climbing 27% ...

Recent developments in health news include GSK's mixed results in cancer treatment trials, Novo Nordisk's market plunge ...

Passed peacefully at home on 9th December 2024, aged 72. Now reunited with her beloved husband, John Clutterbuck. A cherished ...

His mother was a teacher. Chris grew up with a strong sense of social justice, an attribute that his children inherited and ...

Mehdi obtained his MSc Degree in “Molecular Interactions and Therapeutics” from Jules Verne University of Amiens (France). In ...

The latest updates in the health sector involve significant trials and approvals. GSK's ovarian cancer drug trial met its ...

Here’s a look at some of the standout residential light displays giving back to the community across Northeast Ohio.

Four women from Pembrokeshire are planning to row the Atlantic in January for causes very close to their hearts and could ...

The Food and Drug Administration signed off on Vertex Pharmaceuticals' next-generation triple drug for cystic fibrosis late ...

A new CFTR modulator treatment called Alyftrek has been approved for people with CF ages 6 and older who have CFTR mutations ...

The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' next-generation treatment for a rare and ...